Woodline Partners »

Biosante Pharmaceuticals shares owned by Woodline Partners

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.3M 157k 59.66

More positions owned by Woodline Partners

Meta Platforms Cl A (META)
Gilead Sciences (GILD)
Abbvie (ABBV)
Revolution Medicines (RVMD)
Vaxcyte (PCVX)
Asml Holding N V N Y Registry Shs (ASML)
Nuvalent Inc-a (NUVL)
Permian Resources Corp Class A Com (PR)
Encana Corporation (OVV)
Keysight Technologies (KEYS)
Danaher Corporation (DHR)
Aon Shs Cl A (AON)
Stmicroelectronics N V Ny Registry (STM)
Regeneron Pharmaceuticals (REGN)
EQT Corporation (EQT)

View all positions for Woodline Partners

Top funds holding Biosante Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
Dimensional Fund Advisors
State Street Corporation
Ranger Investment Management
Pacer Advisors
Jpmorgan Chase & Co
Citadel Advisors
Global Alpha Capital Management
William Blair Investment Management
Deep Track Capital
Tang Capital Management
Geode Capital Management
Macquarie Group

View all funds holding Biosante Pharmaceuticals